Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

scientific article published in January 2002

Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00002030-200201040-00005
P698PubMed publication ID11741160

P2093author name stringDawn McGuire
Lynn Pulliam
Leonard Kusdra
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectneurotoxicityQ3338704
toxic encephalopathyQ7830379
macrophageQ184204
P304page(s)31-38
P577publication date2002-01-01
P1433published inAIDSQ4651863
P1476titleChanges in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia
P478volume16

Reverse relations

cites work (P2860)
Q40483561Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis
Q33958988Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization
Q37073672Biomarkers of HIV related central nervous system disease
Q35126422Changing patterns in the neuropathogenesis of HIV during the HAART era.
Q39281639Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus
Q34421694Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms
Q37122279Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy
Q28246676Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis
Q24795458Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals
Q90221085HIV-1 Tat: Role in Bystander Toxicity
Q36009246HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment
Q33939729HIV-associated neurocognitive disorder.
Q38809646HIV/neuroAIDS biomarkers.
Q37218005Human immunodeficiency virus-associated dementia: clinical aspects, biology, and treatment
Q38129638Is CD69 an effective brake to control inflammatory diseases?
Q42228175Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis
Q45181283Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort
Q39231455Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell cultures
Q33346244Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients
Q54517758No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV.
Q36982959Osteopontin is increased in HIV-associated dementia
Q33198613Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: A case study
Q35627384Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients
Q31014821The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies
Q36302063The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: information from non-human primate models
Q40394829Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2 alpha, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus

Search more.